Olinvyk
-
Chesterbrook-based Trevena Reduces Workforce, Continues to Evaluate Future Options
Chesterbrook-based Trevena, which was delisted from NASDAQ last month, has brought its workforce down to four full-time employees and is currently evaluating the options for…
-
Chesterbrook-Based Biopharmaceutical Company on Track for Massive Windfall
Trevena, a biopharmaceutical company based in Chesterbrook, has entered into a royalty-based financing deal with an affiliate of R-Bridge Healthcare Fund that could lead to a…
-
Chesterbrook-Based Trevena Receives Milestone Payment from Licensing Partner in China
After the FDA approved its new pain medication, Olinvyk, earlier this month, Chesterbrook-based Trevena has received a $3 million milestone payment from its licensing partner…
-
Chesterbrook-Based Trevena’s Stock Surges After FDA Approves New Pain Med
Chesterbrook-based Trevena saw its stock surge by 50 percent after the FDA approved its new pain medicine on Monday, writes John George for the Philadelphia…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
